中文
|
English
Home
About Us
Return
Company Profile
Company Culture
CEO speech
Corporate Honors
Company strength
Structure
Global layout
Marketing network
Products
Return
Anti-neoplastic Drug Series
Great health Series
Latest products
News
Return
Company News
Industry News
Contact Us
Home
About Us
Return
Company Profile
Company Culture
CEO speech
Corporate Honors
Company strength
Structure
Global layout
Marketing network
Products
Return
Anti-neoplastic Drug Series
Great health Series
Latest products
News
Return
Company News
Industry News
Contact Us
中文
|
English
News
News
Company News
Industry News
Your Current Position:
News
12
2020-08
【Company News】
Ceftriaxone sodium, the major product of the company, was certified by Brazil ANVISA
02
2018-04
【Company News】
The company fluoxetine for the treatment of pigment decolorization disease application project were authorized
18
2018-01
【Company News】
The wind and rain together to write the Spring and Autumn, to join hands and create brilliant! - Warmly celebrate the 27th anniv
28
2017-11
【Company News】
The company participated in the 78th China pharmaceutical fair
29
2017-09
【Company News】
Shandong Province Safety Production Second Inspection Team Visits Ruiying to Inspect and Guide Safety Production Work
10
2017-04
【Company News】
Ruiying Pioneer Intellectual Property Management System Certification Successfully Completed
09
2016-08
【Company News】
Four kind of sterile bulk drug product are approved by the national GMP certification
10
2015-07
【Company News】
Ceftriaxone sodium, the major product of the company, was certified by Brazil ANVISA
10
2015-04
【Company News】
Five kind of sterile bulk drug product and fourteen bulk drug product are approved by the national GMP certification
02
2014-07
【Company News】
A production technology of the company was granted national invention patent
First
<Previous
1
2
3
4
5
6
7
8
9
...
Next>
End